Anaergia (ANRG) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
7 Apr, 2026Business overview and strategy
Operates in 18+ countries with over 230 RNG facilities and 1,750+ technology installations, leveraging a deep IP portfolio and in-house manufacturing in Germany, Italy, and Canada.
Provides end-to-end solutions for converting organic waste into renewable natural gas, clean water, and fertilizer, serving municipalities, agriculture, and food processing sectors.
Vertically integrated model includes capital sales, long-term service contracts, and build-own-operate (BOO) assets, with a capital-light approach and recurring revenue streams.
Strategic partnerships and geographic expansion have strengthened the balance sheet and improved operational execution.
Recent leadership changes and a significant equity investment in 2024 have set a new strategic direction and restored financial discipline.
Technology and innovation
Holds approximately 300 patents worldwide, covering proprietary equipment and processes for organic extraction, digestion, biogas upgrading, and water recycling.
Technology enables processing of diverse feedstocks, maximizes biogas yield, and allows retrofitting of existing infrastructure for rapid deployment.
Dual R&D platform focuses on disruptive innovation and continuous improvements, with commercial deployment at scale.
In-house manufacturing ensures quality control and supply chain reliability.
Market opportunities and regulatory drivers
Regulatory mandates in North America and Europe, such as California SB 1383 and the EU Landfill Directive, are driving demand for new RNG infrastructure.
Over $13B in new RNG infrastructure required in California by 2030; EU targets 1.3B MMBtu of RNG by 2030, requiring ~$78B in investment.
Asia presents growth opportunities due to high organic waste availability and favorable economics for bio-LNG and methanol projects.
Anaergia’s modular systems and local presence provide a competitive advantage in emerging markets.
Latest events from Anaergia
- Record revenue growth, positive EBITDA, and a 149% increase in backlog signal robust prospects.ANRG
Q4 202529 Mar 2026 - Capital-light shift and new leadership drove improved margins and liquidity despite lower revenue.ANRG
Q3 202413 Jan 2026 - Improved margins, major contract wins, and a $103.3M backlog set up strong 2025 growth.ANRG
Q4 202426 Dec 2025 - Backlog rose 94% to CAD 200 million, with improved margins and reduced net loss.ANRG
Q1 202526 Nov 2025 - Revenue up 36.8% and backlog up 137%, with gross margin at 32.5%, signaling strong growth.ANRG
Q2 202523 Nov 2025 - Q3 2025 delivered 77% revenue growth, positive adjusted EBITDA, and a $287M backlog.ANRG
Q3 202517 Nov 2025 - Q2 2024 delivered higher margins and a smaller net loss despite a 45% revenue decline.ANRG
Q2 202413 Jun 2025 - 2023 saw revenue decline, deepening losses, and major restructuring with new strategic investment.ANRG
Q4 202313 Jun 2025 - Revenue declined sharply, but gross profit margin improved on stronger O&M contracts.ANRG
Q1 202413 Jun 2025